Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial

CONCLUSIONS: Immune responses after coadministration of PCV20 and QIV were noninferior to separate administration of either vaccine. The PCV20 safety profile was similar when given together with or after QIV. These findings support PCV20 and QIV coadministration.TRIAL REGISTRATION: ClinicalTrials.gov, NCT04526574.PMID:36828719 | DOI:10.1016/j.vaccine.2022.11.046

Source: Vaccine - February 24, 2023 Category: Allergy & Immunology Authors: Kevin Cannon Jose F Cardona Kari Yacisin Allison Thompson Todd J Belanger Dung-Yang Lee Yahong Peng Lisa Moyer John Ginis William C Gruber Daniel A Scott Wendy Watson Source Type: research